Mackenzie Financial Corp Takes Position in Cutera, Inc. (CUTR)

Mackenzie Financial Corp purchased a new position in Cutera, Inc. (NASDAQ:CUTR) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,690 shares of the medical device company’s stock, valued at approximately $277,000.

Other hedge funds have also recently modified their holdings of the company. Legal & General Group Plc grew its stake in Cutera by 69.6% in the third quarter. Legal & General Group Plc now owns 3,600 shares of the medical device company’s stock worth $149,000 after purchasing an additional 1,477 shares during the period. Greenwood Capital Associates LLC purchased a new stake in Cutera in the third quarter worth $210,000. Dynamic Technology Lab Private Ltd purchased a new stake in Cutera in the third quarter worth $264,000. Nationwide Fund Advisors grew its stake in Cutera by 8.4% in the second quarter. Nationwide Fund Advisors now owns 7,216 shares of the medical device company’s stock worth $187,000 after purchasing an additional 561 shares during the period. Finally, Cubist Systematic Strategies LLC purchased a new stake in Cutera in the second quarter worth $225,000. 87.64% of the stock is currently owned by institutional investors.

Shares of Cutera, Inc. (NASDAQ CUTR) opened at $47.00 on Wednesday. Cutera, Inc. has a 1-year low of $16.55 and a 1-year high of $47.40. The company has a market capitalization of $628.83, a price-to-earnings ratio of 57.12, a price-to-earnings-growth ratio of 1.93 and a beta of 0.53.

Cutera (NASDAQ:CUTR) last released its earnings results on Tuesday, November 7th. The medical device company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.34. Cutera had a return on equity of 18.73% and a net margin of 7.99%. The business had revenue of $38.17 million for the quarter, compared to the consensus estimate of $34.82 million. During the same period in the previous year, the company posted $0.12 earnings per share. The company’s revenue for the quarter was up 26.1% compared to the same quarter last year. equities analysts anticipate that Cutera, Inc. will post 0.55 EPS for the current fiscal year.

In other Cutera news, Director Timothy J. Oshea sold 4,000 shares of the business’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $39.21, for a total value of $156,840.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director David B. Apfelberg sold 1,000 shares of the business’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $42.55, for a total value of $42,550.00. Following the completion of the sale, the director now directly owns 8,055 shares in the company, valued at $342,740.25. The disclosure for this sale can be found here. Insiders sold 14,950 shares of company stock worth $609,770 over the last three months. Corporate insiders own 3.30% of the company’s stock.

Several brokerages recently weighed in on CUTR. BidaskClub raised Cutera from a “hold” rating to a “buy” rating in a research note on Tuesday. Maxim Group reaffirmed a “hold” rating on shares of Cutera in a research note on Wednesday, November 8th. Roth Capital upped their price target on Cutera from $41.00 to $47.00 and gave the stock a “buy” rating in a research note on Tuesday, September 12th. TheStreet raised Cutera from a “c” rating to a “b” rating in a research note on Friday, August 18th. Finally, Zacks Investment Research downgraded Cutera from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $37.33.

WARNING: This story was published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.com-unik.info/2017/12/13/mackenzie-financial-corp-takes-position-in-cutera-inc-cutr.html.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

What are top analysts saying about Cutera? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cutera and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit